Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Daventry Group, LP

Q1 2024 · 13F-HR

Daventry Group, LPholdings as filed

Filed 2024-05-14 · accession 0001172661-24-002249

$250.1M
Reported value
10
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
88025T102TENBTENABLE HLDGS INC$50.7M20.3%1,026,576CommonSOLE
69370C100PTCPTC INC$38.7M15.5%205,051CommonSOLE
159864107CRLCHARLES RIV LABS INTL INC$31.3M12.5%115,662CommonSOLE
418100103HCP2EURHASHICORP INC$29.8M11.9%1,104,036CommonSOLE
N14506104ESTCELASTIC N V$29.3M11.7%291,967CommonSOLE
63947X101NCNONCINO INC$18.1M7.25%485,000CommonSOLE
42225T107HCATHEALTH CATALYST INC$16.3M6.51%2,162,875CommonSOLE
192422103CGNXCOGNEX CORP$15.9M6.36%375,000CommonSOLE
00857U107AGILON HEALTH INC$10.7M4.27%1,750,249CommonSOLE
15687V109CERTCERTARA INC$9.2M3.70%517,167CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.